Xiawei Jiang

Xiawei Jiang

Auto-generated profile, based on publicly available information

Xiawei Jiang

Zhejiang Chinese Medical University, Hangzhou, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Environmental Pollution
Verified
Journal Article
Closed access
XJXiawei Jiang
Xiawei Jiang
WLWenhong Liu
Wenhong Liu
HXHao Xu
Hao Xu
XCXinjie Cui
Xinjie Cui
JLJunfeng Li
Junfeng Li
BZBeiwen Zheng
Beiwen Zheng

20 October 2022 in Frontiers in Microbiology
Verified
Journal Article
Open access
JZJunhui Zhao
Junhui Zhao
BZBeiwen Zheng
Beiwen Zheng
HXHao Xu
Hao Xu
JLJunfeng Li
Junfeng Li
TSTengfei Sun
Tengfei Sun
WLWenhong Liu
Wenhong Liu
Carbapenem-resistant Klebsiella pneumoniae (CRKP) seriously threaten the efficacy of modern medicine with a high associated mortality rate and unprecedented transmission rate. In this study, we isolated a clinical K. pneumoniae strain DY1928 harboring blaNDM-1 from a neonate with blood infection. Antimicrobial susceptibility testing indicated that DY1928 was resistant to various antimicrobial agents, including meropenem, imipenem, ceftriaxone, cefotaxime, ceftazidime, cefepime, piperacillin-tazobactam, and amoxicillin-clavulanate. S1 nuclease-pulsed field gel electrophoresis (S1-PFGE), southern blot and conjugation experiment revealed that the blaNDM-1 gene was located on a conjugative plasmid of IncA/C2 type with a 147.9 kb length. Whole-genome sequencing showed that there was a conservative structure sequence (blaNDM-1-ble-trpF-dsbD) located downstream of the blaNDM-1 gene. Multilocus sequence typing (MLST) classified DY1928 as ST25, which was a hypervirulent K. pneumoniae type. Phylogenetic analysis of genomic data from all ST25 K. pneumoniae strains available in the NCBI database suggested that all blaNDM-1 positive strains were isolated in China and had clinical origins. A mouse bloodstream infection model was constructed to test the virulence of DY1928, and 11 K. pneumoniae strains homologous to DY1928 were isolated from the feces of infected mice. Moreover, we found that DY1928 had a tendency to flow from the blood into the intestine in mice and caused multiple organ damage. To our knowledge, this is the first study to report an infection caused by blaNDM-1-positive ST25 K. pneumoniae in the neonatal unit. Our findings indicated that stricter surveillance and more effective actions were needed to reduce the risk of disseminating such K. pneumoniae strains in clinical settings, especially in neonatal wards.

1 March 2020 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
HHHuiming Han
Huiming Han
WLWenhong Liu
Wenhong Liu
XCXinjie Cui
Xinjie Cui
XCXu Cheng
Xu Cheng
XJXiawei Jiang
Xiawei Jiang
The emergence of the plasmid-borne colistin-resistant gene (mcr-1) poses a great threat to human health. What is worse, the recent observations of the co-existence of mcr-1 with other antimicrobial resistance genes in some bacteria cause further concern. Here, we present the first report of a wild Escherichia coli strain that co-carries an mcr-1 encoding phage-like IncY plasmid (pR15_MCR-1) and a blaNDM-5 encoding IncX3 plasmid (pR15_NDM-5) from a pharmaceutical industry, wastewater treatment plant, in China. This study highlights the spreading of E. coli carrying both mcr-1 and blaNDM-5 genes in the pharmaceutical industry. Importance: Escherichia coli strains that carry both mcr-1 and blaNDM-5 genes are of great health concern and are already found in humans and animals worldwide, yet there is a paucity of observations of this resistant strain in the environment. Here we present the first isolation of an E. coli strain (R15) that co-carries mcr-1 and blaNDM-5 genes from a wastewater treatment plant in China. Whole-genome sequencing indicated that R15 harbored two plasmids, pR15_MCR-1 and pR15_NDM-5, that carry mcr-1 and blaNDM-5, respectively. The observation of this wild-derived E. coli strain that carries mcr-1 and blaNDM-5 genes simultaneously calls for the urgency to improve monitoring and reducing its further spreading.

1 March 2021 in Environmental Pollution
Verified
Journal Article
Closed access
BZBeiwen Zheng
Beiwen Zheng
WLWenhong Liu
Wenhong Liu
HXHao Xu
Hao Xu
JLJunfeng Li
Junfeng Li
XJXiawei Jiang
Xiawei Jiang

30 May 2023 in Public Health
Verified
Journal Article
Closed access
HZH. Zhang
H. Zhang
LZL.R. Zhang
L.R. Zhang
LCL.C. Chu
L.C. Chu
XSX. Sun
X. Sun
XJX.W. Jiang
X.W. Jiang

14 October 2025 in Annals of Clinical Microbiology and Antimicrobials
Verified
Journal Article
Open access
PDF file
XYXiaolu Yang
Xiaolu Yang
ZLZhenghao Lou
Zhenghao Lou
XWXinrui Wang
Xinrui Wang
ZLZhen Li
Zhen Li
QLQiyu Liu
Qiyu Liu
XJXiawei Jiang
Xiawei Jiang
The prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections has surged in China over the past decade, posing a significant public health concern. However, comprehensive data on CRKP antimicrobial resistance patterns and the impact of the COVID-19 pandemic on these patterns in China remain unclear. We conducted a systematic review of CRKP infections in China, utilizing data from PubMed spanning 2006 to July 2023. We focused on resistance rates of CRKP causing infections, examining variations across time, regions, and age groups, as well as factors contributing to antimicrobial resistance. Our analysis included 68 studies from 19 provinces in China, comprising 1,284 CRKP isolates obtained from 779 patients. The overall mortality rate for CRKP infections in China was 27% (95% CI: 0.14–0.41, I2 = 73%, k = 47), with ST11 being the predominant sequence type (Pooled Rate: 80%, 95% CI: 0.67–0.90, I2 = 86%, k = 31). Temporal and spatial analyses indicated increased resistance to ciprofloxacin (Random effects model: Qb = 9.88, df = 1, P < 0.010) and levofloxacin (Random effects model: Qb = 7.69, df = 1, P < 0.010) during the COVID-19 pandemic. Resistance to chloramphenicol (Random effects model: Qb = 4.97, df = 1, P = 0.030) and ceftazidime-avibactam (Random effects model: Qb = 8.58, df = 1, P < 0.010) was lower in southern regions, while tetracycline resistance (Random effects model: Qb = 9.69, df = 1, P < 0.010) was lower in the north. Higher resistance rates were observed in adults and the elderly. Age and geographic location were key factors associated with antimicrobial resistance. Fourteen out of thirty-five drugs showed a positive correlation with mortality rates, emphasizing their significant impact on CRKP infection mortality. This study underscores the need for targeted interventions to address regional and age-related variations in CRKP resistance and highlights the critical role of antimicrobial resistance in influencing mortality outcomes.